Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders (Diabetic Retinopathy, Dry AMD, Hard Drusen Formation) for Alzheimer's Disease Prevention

NCT03859245 is registered in ClinicalTrials.gov with Bristlecone Health, Inc. as lead sponsor.

NCT NCT03859245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03859245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders (Diabetic Retinopathy, Dry AMD, Hard Drusen Formation) for Alzheimer's Disease Prevention
Lead sponsor
Bristlecone Health, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 23, 2019
Completion date
September 30, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration (amd), diabetic macular edema (dme), diabetic retinopathy (dr), mid-peripheral drusen formation